Coppi G, Gatti M T, Mosconi P, Berti M A
Proter Research Laboratories, Milan, Italy.
Arch Int Pharmacodyn Ther. 1988 Jul-Aug;294:283-94.
The effects of 3 alpha, 7 beta-dihydroxy-12-cheto-cholan-24-oic acid (SF-482) were compared with those of ursodeoxycholic acid on bile flow and composition, on gallstones formation and on experimental hyperlipemias. SF-482, like ursodeoxycholic acid, increases the bile flow and residue in normal and ethynylestradiol-treated rats. The two compounds increase the biliary excretion of bile acids and phospholipids with a desaturation of bile cholesterol. SF-482 and ursodeoxycholic acid decrease the incidence of gallstones in mice; both compounds are active in Triton WR-1339, in olive oil and margarine hyperlipemias in rats and in ethanol intoxication in mice. In general, SF-482 is more active than ursodeoxycholic acid.
将3α,7β - 二羟基 - 12 - 酮胆烷 - 24 - 酸(SF - 482)与熊去氧胆酸对胆汁流量和成分、胆结石形成以及实验性高脂血症的影响进行了比较。与熊去氧胆酸一样,SF - 482可增加正常大鼠和乙炔雌二醇处理大鼠的胆汁流量及胆汁残留量。这两种化合物均可增加胆汁酸和磷脂的胆汁排泄量,并使胆汁胆固醇去饱和。SF - 482和熊去氧胆酸均可降低小鼠胆结石的发生率;二者对大鼠的吐温WR - 1339、橄榄油和人造黄油性高脂血症以及小鼠的乙醇中毒均有活性。总体而言,SF - 482比熊去氧胆酸活性更强。